Single-cell study sheds new light on why ovarian cancer becomes resistant to chemotherapy

August 26, 2025

Researchers at the Cancer Research UK Cambridge Institute and Stanford University have mapped how ovarian cancer cells respond to chemotherapy at an unprecedented level of detail, offering new insights into why treatment resistance develops.
Single-cell study sheds new light on why ovarian cancer becomes resistant to chemotherapy
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect